1 2 8 VOLUME 18 | NUMBER 1 | JANUARY 2012 nAture medicine Sepsis and sepsis-associated multiorgan failure are major causes of death worldwide [1][2][3] . During sepsis, some people die early from bacteremia or from sepsis-induced hyperinflammation, an uncontrolled overactivation of the innate immune system with initiation of the complement system and high amounts of circulating proinflammatory cytokines 4, 5 . Notably, the neutralization of inflammatory mediators with glucocorticosteroids 6 , endotoxin-specific antibodies 7 , tumor necrosis factor (TNF) inhibitors 8,9 or interleukin-1 (IL-1) receptor antagonists 10 does not improve the overall survival of people with sepsis. Some affected individuals die from secondary infections during the phase of SAIS 3, 11, 12 , which is characterized by cutaneous anergy to recall skin antigens 12 , neutrophil paralysis 13 , lymphopenia 14 , lower amounts of circulating proinflammatory cytokines (TNF, IL-6) 15 and increased IL-10 levels 16, 17 . Systems analyses of endotoxin-stimulated macrophages have identified ATF3 as a rapidly induced transcription factor of endotoxin-stimulated macrophages and have found that ATF3 strongly represses IL-6 transcription 18, 19 . ATF3 also reduces TNF-and IL-6-dependent airway hyper-reactivity and interferon-γ production in cytomegalovirus-infected mice 20, 21 . Because ROS deplete GSH 18, 22 during SAIS, and GSH depletion enhances endotoxin-induced ATF3 expression, we investigated the role of ROS-induced ATF3 expression and ATF3-mediated IL-6 suppression in lipopolysaccharide (LPS)-induced shock, in bacterial or fungal sepsis, and during SAIS.
controls (Fig. 1b) . Low ATF3 correlated with high IL-6 levels ( Fig. 1) . Table 1 ), ATF3 mRNA and protein levels significantly increased during SAIS (Fig. 1b,c) . The increased ATF3 directly correlated with the decreased GSH (r 2 = -0.49; P < 0.05; Supplementary Fig. 1a,b) . This inverse correlation between ATF3 and GSH may be physiologically relevant, because ATF3 suppresses TNF, IL12B and IL6 transcription 18 . Accordingly, IL-6 serum levels were high during acute sepsis and significantly lower during SAIS (Fig. 1d) .
Until patients left the ICU (Supplementary

ROS stress superinduces ATF3 and abrogates IL-6 production
To model sepsis-induced GSH depletion in vitro, we depleted GSH in CD14 + human monocytes using dimethylfumarate (DMF). DMF diminished intracellular GSH to 40-50% of its concentration in controls (Fig. 2a) , levels similar to those measured during SAIS in human blood. Flow cytometry revealed that GSH depletion by DMF increased intracellular ROS to the same extent as did H 2 O 2 treatment (Fig. 2a) . N-acetylcysteine (NAC) restored intracellular GSH and returned ROS to normal levels (Fig. 2a) . As in mouse macrophages 18 , LPS stimulation of CD14 + human monocytes increased ATF3 mRNA expression two-to threefold, with a maximum at 2 h (Fig. 2b) . To selectively mimic ROS stress during SAIS, we depleted GSH in CD14 + human monocytes, stimulated them with LPS and measured ATF3 mRNA and protein levels 2 h later. After GSH depletion, LPS superinduced ATF3 mRNA about fivefold (Fig. 2c) . This resulted in 12-fold greater ATF3 mRNA expression compared to unstimulated cells (Fig. 2b,c) , equivalent to the tenfold ATF3 mRNA increase measured during SAIS in vivo (Fig. 1b) . NAC restored normal ROS levels ( Fig. 2a) and prevented superinduction of ATF3 mRNA in GSH-depleted monocytes (Fig. 2c) . Because ATF3 negatively regulates IL-6 and IL-12 p40 (ref. 18) , cytokines that are crucial in both LPS-induced shock and pathogen defense, we determined whether the ATF3 superinduction caused by GSH depletion affected the expression of IL6 or IL12B mRNAs in CD14 + monocytes or their protein production in peripheral blood mononuclear cells (PBMCs). GSH depletion suppressed the LPS-induced IL6 or IL12B mRNA by 80-90%; NAC fully reversed this suppression (Fig. 2d) . GSH depletion also suppressed IL-6 or IL-12 p40 protein production (Supplementary Fig. 1c) . In addition, DMF impaired LPS-induced TNF expression ( Supplementary  Fig. 1c) , and NAC reversed ATF3 superinduction and restored the LPS-induced expression and production of ATF3-regulated cytokines ( Fig. 2d and Supplementary Fig. 1c ). To determine whether ATF3 superinduction caused the ROS-mediated suppression of IL-6, IL-12 p40 and TNF, we selectively impaired ATF3 translation using ATF3-specific short interfering RNA (siRNA; Fig. 2e ). We depleted GSH in ATF3-knockdown monocytes or control siRNA-transfected monocytes, stimulated them with LPS and measured IL-6 production. In monocytes transfected with control siRNAs, GSH depletion caused ATF3 superinduction and suppressed IL-6 production to <10% of the level seen in untreated monocytes (Fig. 2f) . The DMF-treated ATF3-knockdown monocytes produced fourfold more IL-6 than DMF-treated monocytes transfected with the control siRNA. Thus, ROS-induced ATF3 protein is required to inhibit LPS-triggered IL-6 production by human monocytes. The ATF3 knockdown did not affect IL-12 p40 or TNF (data not shown).
ROS-mediated ATF3 superinduction requires NRF2
To determine the functional relevance of ROS-induced increases in ATF3 during SAIS after bacterial sepsis or sepsis-induced hyperinflammation, we studied GSH depletion in C57BL/6 (wild-type) mice or congenic C57BL/6 × Atf3 −/− mice. DMF diminished GSH levels in macrophages of wild-type or Atf3 −/− mice by 70%, and NAC prevented this GSH depletion (Supplementary Fig. 2a ). DMF and H 2 O 2 induced similar ROS increases in wild-type and Atf3 −/− macrophages, and these increases were fully reversed by NAC (Supplementary Fig. 2b ). LPS increased Atf3 mRNA levels two-to threefold in mouse macrophages 18 (and data not shown), and GSH depletion again significantly (P < 0.05) superinduced Atf3 mRNA levels in response to LPS (Fig. 3a,b) .
NRF2, which is a ROS-sensitive transcription factor, is rapidly degraded in the cytoplasm under normal oxidative conditions 25 . During ROS stress, NRF2 accumulates in the nucleus and binds antioxidant response elements (AREs) of various promoter regions, including the ATF3 promoter 26 . GSH depletion dose-dependently increased nuclear NRF2 protein, as did the NRF2 activators tBHQ and BHA (Fig. 3c) . GSH depletion also increased NRF2 binding to ARE1 in the ATF3 promoter (Fig. 3d) . The enhanced NRF2 binding was functional, as shown in mouse macrophage RAW lines and in human astrocytes transfected with various ATF3 promoter-luciferase constructs. Notably, NRF2 bound intact but not mutated ARE1. NRF2 binding induced luciferase approximately twofold after GSH depletion or tBHQ treatment ( Fig. 3e and Supplementary Fig. 2c ). Western blots from mouse bone marrow-derived dendritic cells (BMDCs) highlighted the functional relevance of this binding. In the absence of ROS stress, LPS moderately induced ATF3 (Fig. 3f) . GSH depletion Figure 1 Declining glutathione levels correlate with increasing ATF3 and decreasing IL-6 levels during SAIS. We collected blood from subjects with sepsis (n = 16, subjects 1-16; two subjects died during sepsis, and four did not provide postsepsis samples; see Supplementary (Fig. 3f) . Therefore, GSH-mediated ATF3 superinduction required the nuclear binding of NRF2 to the ARE1 promoter region of ATF3.
ROS-mediated ATF3 superinduction abrogates IL-6 production GSH depletion abrogated LPS-induced Il6 and Il12b mRNA in mouse macrophages, and NAC fully reversed this suppression (Supplementary Fig. 2d ). In wild-type macrophages, GSH depletion suppressed the LPS-induced production of IL-6, IL-12 p40 or IL-1β
by ≥90% and of TNF by 50%, and NAC again reversed this suppression (Fig. 3g) . In the absence of GSH depletion, Atf3 −/− macrophages produced amounts of innate cytokines similar to wild-type macrophages. In contrast, the Atf3 −/− macrophages were largely resistant to ROS-induced IL-6 suppression (Fig. 3g) . This demonstrates that the ROS-mediated superinduction of ATF3 directly silences IL-6. In contrast, ATF3 suppressed IL-12 p40 and TNF only partially, and did not affect IL-1β production (Fig. 3g) . These results were confirmed in BMDCs (Supplementary Fig. 3a ) and were independent of apoptosis or necrosis induction (Supplementary Fig. 3b ). 1,500 500 500 NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001 (t test (f) or ANOVA).
npg ROS stress establishes resistance to endotoxin-induced shock Sepsis and SAIS are complex diseases that affect multiple molecular signaling cascades 2,3,12 .
To study the functional relevance of ROSmediated GSH depletion in vivo, which is a hallmark of SAIS 12 , we diminished GSH by feeding mice DMF (Supplementary Fig. 4a ). DMF-treated mice had similar GSH blood concentrations as humans or mice with SAIS ( Fig. 1a and Supplementary Figs. 1 and 4) . GSH depletion also significantly enhanced endotoxin-induced Atf3 mRNA expression in peritoneal macrophages in vivo (Fig. 4a) . Because low ATF3 sensitizes mice to endotoxic (LPS-induced) shock 18 , ATF3 superinduction by GSH depletion should protect mice against LPSinduced shock. Indeed, in vivo depletion of GSH by DMF treatment (Supplementary Fig. 4a ) protected >80% of mice against LPS-induced shock in conditions that rapidly killed 50% of controls (Fig. 4b,c) . This LPS resistance strictly required GSH depletion, as NAC treatment to prevent GSH depletion restored susceptibility to LPS-induced shock ( Supplementary Fig. 4a,b) . DMF-mediated protection from LPS-induced shock correlated with substantial suppression of Il6, Tnf and Il12b mRNA expression in the spleen and of the corresponding protein expression in serum ( Fig. 4d and Supplementary Fig. 4c,d ).
Together, these data suggest that GSH depletion protects against LPS-induced shock and that this protection is at least partially mediated through the superinduction of ATF3. Therefore, we challenged the DMF-treated Atf3 −/− mice with LPS. As in wild-type mice, DMF diminished GSH in Atf3 −/− mice by 50% ( Supplementary  Fig. 4a ). However, in contrast to the DMF-treated wild-type mice, GSH depletion suppressed neither the LPS-induced Tnf expression nor the production of IL-6 or IL-12 p40 in Atf3 −/− mice ( Fig. 4d and Supplementary Fig. 4c,d) . Moreover, GSH depletion did not protect the Atf3 −/− mice against LPS-induced shock (Fig. 4b,c) . ) and treated with antibiotics as described in Online Methods. Data represent two independent experiments (n = 5-6 mice per group per experiment). (g) Bacterial load in blood of mice in f, 24 h after E. coli injection (n = 6 mice per group; data are means ± s.d.). *P < 0.05; **P < 0.01; ***P < 0.001 (t test (c) or log-rank statistic).
npg Therefore, ROS-induced ATF3 directly suppressed the innate immune response to endotoxins and prevented endotoxin-induced shock.
ROS-induced ATF3 abrogates innate control of bacterial sepsis
Although ROS-induced GSH depletion protected against LPS-induced shock via NRF2-dependent superinduction of ATF3, the attenuation of the cytokine storm by ATF3 may render mice and humans more vulnerable to bacterial and fungal infections. To address this possibility, we studied fungal and Escherichia coli sepsis and bacterial peritonitis (cecal ligation and puncture, CLP), three important model diseases of human sepsis 27 . In conditions that killed 20% of watertreated controls, CLP killed 80% of DMF-treated mice (Fig. 5a) . The ROS-mediated induction of ATF3 directly caused this susceptibility to bacteremia, as 80% of the Atf3 −/− mice were even protected against CLP conditions that killed 100% of wild-type mice (Fig. 5b) . Moreover, after CLP, the peritoneal lavage of Atf3 −/− mice contained only 10% of the bacteria found in Atf3 wild-type mice (Fig. 5c) . In addition, Atf3 −/− mice were largely protected from E. coli-or Aspergillus fumigatus-induced sepsis (Supplementary Fig. 5a-d) , indicating that ATF3 activation attenuated the control of systemic bacterial or fungal infection. To determine whether ROS-mediated ATF3 induction causes increased susceptibility to bacterial sepsis, we depleted GSH in wild-type and Atf3 −/− mice using DMF and then performed CLP in conditions that killed approximately 50% of undepleted wild-type mice (Fig. 5d) . After GSH depletion, this CLP condition killed all wild-type mice (Fig. 5d) . In contrast, GSH depletion did not attenuate the protection against CLP in Atf3 −/− mice (Fig. 5d) . In line with this, GSH depletion enhanced the CLP-induced expression of ATF3 protein in peritoneal macrophages of wild-type mice (Supplementary Fig. 6a ) and suppressed the CLP-induced expression of IL-6 and IL-12 p40 serum proteins in wild-type mice. Atf3 −/− mice had significantly higher IL-6 and IL-12 p40 serum levels than wild-type mice (P < 0.05), but only slightly higher TNF levels (Supplementary Fig. 6b ).
Control of bacterial or fungal infections requires IL-6 (ref. 28).
To test whether ATF3 also attenuates IL-6-or TNF-independent inflammation, we analyzed GPI-induced arthritis, which requires IL-1 but not IL-6 (ref. 29) . This inflammation was ATF3-independent, as arthritis was similar in the Atf3 −/− and wild-type mice (Supplementary Fig. 7 ).
ATF3-mediated IL-6 suppression sensitizes for bacterial sepsis ROS-induced ATF3 severely suppressed serum IL-6 during bacteremia. To determine whether the ATF3-mediated suppression of IL-6 caused the susceptibility to CLP, we studied CLP in Atf3 −/− Il6 −/− doubleknockout mice (Fig. 5e) . In CLP conditions that killed 100% of the wild-type mice, 70% of the Atf3 −/− mice survived (Fig. 5e) . However, 100% of the Atf3 −/− Il6 −/− mice died from this CLP (Fig. 5e) , indicating that the ATF3-mediated IL-6 suppression directly caused the high susceptibility of the wild-type mice to CLP. Therefore, the endotoxinmediated induction of ATF3 provided robust protection against LPSinduced shock while strongly enhancing susceptibility to bacteremia. ROS-mediated GSH depletion amplified both of these effects, an outcome reminiscent of SAIS.
To more closely mimic SAIS in hospitalized patients with antibiotic therapy, we induced E. coli sepsis, a frequent cause of sepsis in humans 30 . Antibiotics protected 100% of mice infected with 1 × 10 6 colony-forming units (c.f.u.) of E. coli; this dose caused 60% mortality in untreated mice (Supplementary Fig. 5a ). At 1 × 10 10 c.f.u. of E. coli, the antibiotics protected only 30% of the wild-type mice but 70% of the Atf3 −/− mice (Supplementary Fig. 5b ; P < 0.05), which demonstrates that ATF3 enhanced susceptibility to bacterial sepsis during antibiotic therapy. Moreover, GSH depletion increased E. coliinduced mortality and bacteremia in antibiotic-treated wild-type mice (Fig. 5f,g ) and increased Atf3 mRNA levels but decreased serum IL-6 and IL-12 p40 protein abundance (Supplementary Fig. 5c ).
ATF3 causes susceptibility to secondary infections during SAIS SAIS causes high susceptibility to secondary infections by bacterial, viral and fungal pathogens. The causes of SAIS remain unknown, but they are correlated with high ROS levels and the depletion of GSH 11, 23, 24 . During SAIS, decreasing GSH levels were inversely , and cytokine levels in serum after 16 h (f; IL-10 not detectable) in WT mice treated with DMF (GSH-depl.) or water for 10 d, then subjected to sublethal CLP and injected with a nonlethal dose of A. fumigatus (n = 13-17 mice per group). ATF3 blots were normalized to β-actin using the ImageJ software program. *P < 0.05 (t test); **P < 0.01 (log-rank statistic).
npg correlated with ATF3 induction (Fig. 1a,b) , and GSH depletion caused high, ATF3-dependent susceptibility to bacterial and fungal pathogens. These results suggest that ATF3 induction is an important contributor to SAIS and to the severe susceptibility to secondary infections. To investigate this, we first induced sublethal CLP, a well-established model of SAIS 31, 32 , in wild-type and Atf3 −/− mice. During immunosuppression, we then challenged the mice with the fungal pathogen A. fumigatus at doses that were nonpathogenic to healthy mice. During SAIS, all of the wild-type mice died from this sublethal A. fumigatus infection within 8 d; the Atf3 −/− mice lived significantly longer, and 20% of the Atf3 −/− mice survived this challenge (Fig. 6a) . To further aggravate the GSH depletion, we treated mice with DMF during SAIS. This additional GSH depletion enhanced the susceptibility of the immunosuppressed mice to A. fumigatus (Fig. 6b) , further diminished the already low GSH abundance (Fig. 6c) , increased the fungal load (Fig. 6d) , superinduced ATF3 protein (Fig. 6e) and decreased serum IL-6 and IL-12 p40 abundance ( Fig. 6f and Supplementary Fig. 5e) . Thus, the ROS-induced increase in ATF3 expression caused the susceptibility to acute bacterial and fungal infections and contributed to SAIS and the high sensitivity to secondary infections.
DISCUSSION
Here we have shown that ROS-mediated depletion of GSH, which is the primary cellular ROS scavenger, strongly superinduces endotoxintriggered ATF3 in human monocytes and mouse macrophages in response to TLR signals. This was demonstrated in human subjects with sepsis, septic mice and GSH-depleted mice. ROS-mediated ATF3 superinduction required nuclear translocation of the ROS-sensitive transcription factor NRF2 after GSH depletion and NRF2 binding to the ATF3 promoter. ATF3 superinduction severely impaired the endotoxin-induced production of innate cytokines (Supplementary Fig. 8 ), which protected against endotoxin-induced lethal shock. However, ATF3-mediated suppression of the innate cytokine storm (specifically of IL-6) abrogated the control of bacteria and fungi and caused high susceptibility to secondary infections. This indicates that IL-6 is crucial for controlling bacterial and fungal infections, whereas silencing of additional cytokines is required to attenuate LPS-induced shock. The key role of a single transcription factor, ATF3, in determining the outcome of SAIS surprised us, because SAIS is a complex disease associated with severe impairment of multiple immune functions [12] [13] [14] [15] [16] [17] . Until now, to our knowledge no single target molecule of therapeutic value has been identified 3,12 , and clinical trials targeting the 'sepsis complex' with a single compound have not improved overall survival 3,6-10 . Our data reveal that sepsis-associated ROS stress itself sensitizes monocytes and macrophages to TLR-mediated ATF3 superinduction. This ATF3 superinduction may protect against acute stresses that mimic LPS-induced shock, such as mechanical lung ventilation, acute kidney injury or allergen exposure 18, 21, 22, 33, 34 , certain chemicals, avian flu, or systemic TLR triggers that cause rapid lung injury and death 5, 35, 36 but are attenuated by neutralization of innate cytokines 18, [37] [38] [39] .
In contrast, ATF3 induction during SAIS increases susceptibility to secondary infections 2,3,12 , and treatment with antioxidants, such as NAC, may be beneficial. NAC improves the survival of mice with severe bacterial infection 40 and peroxidative indices and clinical scores in people with sepsis 41 . However, NAC does not improve the overall survival of people with sepsis 41 . Our results support a potential benefit of NAC during sepsis, but in clinical studies NAC therapy requires clearly defined patient populations and correct dosing and timing. Several reports support this view: appropriate neutrophil recruitment by IL-33 improves bacterial clearance and survival in CLP 42 ; restoring the production of interferon-γ by monocytes improves the outcome of sepsis in humans 43 ; and negative regulators of TLRs, such as IRAK-M and ST2, enhance susceptibility to secondary infections 44, 45 .
Our results are reminiscent of those in Tlr4 −/− or Tnf −/− mice, yet they extend further these findings 27, 37, [46] [47] [48] [49] . First, ATF3 regulation by ROS differentially determined the susceptibility to either endotoxins such as LPS or to pathogens such as bacteria and fungi. Second, a single ROS-regulated transcription factor had opposing effects on LPS-induced shock and on septicemia. This explains why endotoxin shock, septicemia and SAIS require different treatment protocols and why studies of treatments that do not improve the overall survival of individuals with sepsis frequently identify subpopulations who do benefit 50, 51 . Therefore, GSH and ATF3 expression in PBMCs may be reliable parameters to monitor susceptibility to secondary infections. Moreover, because ATF3 can be regulated by GSH in vivo, our data suggest ATF3 as a powerful target for prophylactic or therapeutic intervention in endotoxic shock, bacterial sepsis or SAIS.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
Quantitative PCR, short interfering RNA, western blotting, luciferase reporter assay and chromatin immunoprecipitation. For the quantitative PCR analysis, RNA from the defined cell populations, whole spleens, PBMCs, or human (PAXgene RNA tubes) or mouse blood was isolated using the NucleoSpin RNA II kit (Macherey-Nagel) or the Peqlab Total RNA kit (Peqlab). After the DNase digestion, cDNA synthesis was performed using the SuperScript III FirstStrand Synthesis SuperMix (Invitrogen) or the Sensiscript RT kit (Qiagen). For the relative quantification by quantitative PCR, 20 ng of each cDNA sample was analyzed in a LightCycler 480 Real-Time PCR System using the FastStart DNA Master plus SYBR Green I kit (Roche Diagnostics). The sequences of the primer pairs are reported in the Supplementary Methods. The relative gene expression was normalized to that of the housekeeping gene G6PDH or β-actin and expressed in relative units. Where indicated, the results were normalized to the controls. For the knockdown experiments, ATF3-specific siRNA (a pool of three target-specific 19-to 25-nt siRNAs) and control siRNA were purchased from Santa Cruz Biotechnology, and the knockdown was performed according to the manufacturer's instructions. Briefly, human CD14 + monocytes (0.5 × 10 6 cells) were transfected with 60 pmol siRNA (ATF3 or control) using the transfection reagent and transfection medium (Sigma-Aldrich) for 72 h. The cells were then incubated with the control medium or DMF (70 µM) and stimulated with LPS (10 ng ml −1 ). ATF3 expression was analyzed by western blotting, and cytokine production was analyzed using ELISA. For the western blot analyses, we prepared the cellular extracts by lysing the cells in SDS-PAGE sample loading buffer and boiling them at 95 °C for 5 min. The proteins were resolved in 4-20% gradient SDS/PAGE gels and transferred to a PVDF membrane, which was blocked with 5% milk and TBS plus Tween and hybridized overnight at 4 °C with an ATF3-specific, NRF2-specific (both Santa Cruz) or β-actin-specific (Cell Signaling) antibody in TBS plus Tween. After incubation with a secondary antibody (Cell Signaling), the blots were developed with enhanced chemiluminescence (Pierce). In some experiments, the blots were analyzed quantitatively using image analysis software (Image J). For the luciferase reporter assays, RAW cells and human astrocytes were transfected using PolyFect reagents (Qiagen) with ATF3 promoter-luciferase constructs 26 . All of the cells were cotransfected with the β-galactosidase expression vector (pSV-β-galactosidase). Luciferase activity was measured using the Luciferase Assay System (Promega), and β-galactosidase activity was measured using O-nitrophenyl β-galactopyranoside. Chromatin immunoprecipitation was performed using the ChIP kit (Upstate Biotechnology). ARE1 in the ATF3 promoter was amplified by PCR using primers listed in the Supplementary Methods. Glutathione assay, flow cytometry and ELISA. We measured the intracellular and plasma glutathione levels in mouse and human cells using a colorimetric assay (Sigma-Aldrich) 54 . The content of glutathione in whole blood was determined using HPLC (in the laboratory of A. Bayer). To measure apoptosis in cell culture, we used an Annexin V/PI staining kit (BD). The ELISAs were performed according to the manufacturers' instructions (BD and eBioscience). In some experiments, mouse serum was analyzed with a Cytometric Bead Array according to the manufacturer's instructions (BD).
Lipopolysaccharide-induced endotoxemia, and bacterial and fungal sepsis models. In some experiments, the mice (C57BL/6 and Atf3 −/− ) were treated orally with DMF (400 µg daily) or DMF plus NAC (1600 µg daily) for 5-10 d. For the endotoxemia experiments, the mice were challenged intraperitoneally with LPS (20 mg per kg body weight; Sigma-Aldrich), and body temperatures were recorded in the rectum with a BAT thermometer (WPI). Bacterial peritonitis was induced with an intraperitoneal injection of 10 6 -10 10 c.f.u. of E. coli ATCC25922. The mice were treated with ceftriaxone (100 mg kg −1 intraperitoneally) plus gentamicin (20 mg per kg body weight intraperitoneally) 1 h after the E. coli injection and then with ceftriaxone alone every 24 h. The CLP experiments (C57BL/6, Atf3 −/− , Il6 −/− or Atf3 −/− Il6 −/− mice) were performed as described 27 . Where mentioned, the mice were infected intravenously with A. fumigatus (2 × 10 6 -3 × 10 6 conidia). Blood samples, peritoneal lavage and livers were harvested to quantify bacterial and fungal contents. Liver cell suspensions were prepared, serial dilutions were generated and 50-100 µl of each dilution was plated on tryptic soy or Sabouraud glucose agar with antibiotic (Fisher Scientific). The plates were incubated for 1-2 d at 37 °C, and the c.f.u. were counted.
Statistical analyses. Parametric data were analyzed using the unpaired Student's t test. For the nonparametric data, the Wilcoxon rank-sum test was used (ANOVA). For the survival studies, the log-rank test was used to determine significance. Pearson's correlation was used to calculate the correlation. A P value of <0.05 was considered to be statistically significant; P values of <0.01 and <0.001 are indicated separately. 
